|
1
|
Wellings SR and Jensen HM: On the origin
and progression of ductal carcinoma in the human breast. J Natl
Cancer Inst. 50:1111–1118. 1973.PubMed/NCBI
|
|
2
|
Wellings SR, Jensen HM and Marcum RG: An
atlas of subgross pathology of the human breast with special
reference to possible precancerous lesions. J Natl Cancer Inst.
55:231–273. 1975.PubMed/NCBI
|
|
3
|
Wellings SR: A hypothesis of the origin of
human breast cancer from the terminal ductal lobular unit. Pathol
Res Pract. 166:515–535. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Allred DC, Mohsin SK and Fuqua SA:
Histological and biological evolution of human premalignant breast
disease. Endocr Relat Cancer. 8:47–61. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Musumeci G, Castrogiovanni P, Szychlinska
MA, Aiello FC, Vecchio GM, Salvatorelli L, Magro G and Imbesi R:
Mammary gland: From embryogenesis to adult life. Acta Histochem.
117:379–385. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma XJ, Salunga R, Tuggle JT, Gaudet J,
Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang BM, et
al: Gene expression profiles of human breast cancer progression.
Proc Natl Acad Sci USA. 100:5974–5979. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sotiriou C, Neo SY, McShane LM, Korn EL,
Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL and Liu ET: Breast
cancer classification and prognosis based on gene expression
profiles from a population-based study. Proc Natl Acad Sci USA.
100:10393–10398. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fu J, Allen W, Xia A, Ma Z and Qi X:
Identification of biomarkers in breast cancer by gene expression
profiling using human tissues. Genom Data. 2:299–301. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tripathi A, King C, de la Morenas A, Perry
VK, Burke B, Antoine GA, Hirsch EF, Kavanah M, Mendez J, Stone M,
et al: Gene expression abnormalities in histologically normal
breast epithelium of breast cancer patients. Int J Cancer.
122:1557–1566. 2008. View Article : Google Scholar
|
|
10
|
Martinez-Outschoorn UE, Lin Z,
Whitaker-Menezes D, Howell A, Sotgia F and Lisanti MP: Ketone body
utilization drives tumor growth and metastasis. Cell Cycle.
11:3964–3971. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nieman KM, Kenny HA, Penicka CV, Ladanyi
A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB,
Hotamisligil GS, et al: Adipocytes promote ovarian cancer
metastasis and provide energy for rapid tumor growth. Nat Med.
17:1498–1503. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hancke K, Grubeck D, Hauser N, Kreienberg
R and Weiss JM: Adipocyte fatty acid-binding protein as a novel
prognostic factor in obese breast cancer patients. Breast Cancer
Res Treat. 119:367–377. 2010. View Article : Google Scholar
|
|
13
|
Uehara H, Takahashi T, Oha M, Ogawa H and
Izumi K: Exogenous fatty acid binding protein 4 promotes human
prostate cancer cell progression. Int J Cancer. 135:2558–2568.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim S, Lee Y and Koo JS: Differential
expression of lipid metabolism-related proteins in different breast
cancer subtypes. PLoS One. 10:e01194732015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lippman M, Bolan G and Huff K: The effects
of glucocorticoids and progesterone on hormone-responsive human
breast cancer in long-term tissue culture. Cancer Res.
36:4602–4609. 1976.PubMed/NCBI
|
|
16
|
Goya L, Maiyar AC, Ge Y and Firestone GL:
Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat
mammary tumor cells that is synchronously reversed by steroid
withdrawal or addition of transforming growth factor-alpha. Mol
Endocrinol. 7:1121–1132. 1993.PubMed/NCBI
|
|
17
|
Rubiś B, Grodecka-Gazdecka S, Lecybył R,
Ociepa M, Krozowski Z and Trzeciak WH: Contribution of protein
kinase A and protein kinase C signalling pathways to the regulation
of HSD11B2 expression and proliferation of MCF-7 cells. Acta
Biochim Pol. 51:919–924. 2004.
|
|
18
|
Song X, Siriwardhana N, Rathore K, Lin D
and Wang HC: Grape seed proanthocyanidin suppression of breast cell
carcinogenesis induced by chronic exposure to combined
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene.
Mol Carcinog. 49:450–463. 2010.PubMed/NCBI
|
|
19
|
Koyama K, Myles K, Smith R and Krozowski
Z: Expression of the 11beta-hydroxysteroid dehydrogenase type II
enzyme in breast tumors and modulation of activity and cell growth
in PMC42 cells. J Steroid Biochem Mol Biol. 76:153–159. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rabbitt EH, Gittoes NJ, Stewart PM and
Hewison M: 11beta-hydroxysteroid dehydrogenases, cell proliferation
and malignancy. J Steroid Biochem Mol Biol. 85:415–421. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lipka C, Mankertz J, Fromm M, Lübbert H,
Bühler H, Kühn W, Ragosch V and Hundertmark S: Impairment of the
antiproliferative effect of glucocorticosteroids by
11beta-hydroxysteroid dehydrogenase type 2 overexpression in MCF-7
breast-cancer cells. Horm Metab Res. 36:437–444. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smith-Kirwin SM, O'Connor DM, De Johnston
J, Lancey ED, Hassink SG and Funanage VL: Leptin expression in
human mammary epithelial cells and breast milk. J Clin Endocrinol
Metab. 83:1810–1813. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
O'brien SN, Welter BH and Price TM:
Presence of leptin in breast cell lines and breast tumors. Biochem
Biophys Res Commun. 259:695–698. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sheffield L: Malignant transformation of
mammary epithelial cells increases expression of leptin and leptin
receptor. Endocr Res. 33:111–118. 2008. View Article : Google Scholar
|
|
25
|
Ishikawa M, Kitayama J and Nagawa H:
Enhanced expression of leptin and leptin receptor (OB-R) in human
breast cancer. Clin Cancer Res. 10:4325–4331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tessitore L, Vizio B, Jenkins O, De
Stefano I, Ritossa C, Argiles JM, Benedetto C and Mussa A: Leptin
expression in colorectal and breast cancer patients. Int J Mol Med.
5:421–426. 2000.PubMed/NCBI
|
|
27
|
Cleary MP, Phillips FC, Getzin SC,
Jacobson TL, Jacobson MK, Christensen TA, Juneja SC, Grande JP and
Maihle NJ: Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female
mice do not develop mammary tumors. Breast Cancer Res Treat.
77:205–215. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu X, Juneja SC, Maihle NJ and Cleary MP:
Leptin - a growth factor in normal and malignant breast cells and
for normal mammary gland development. J Natl Cancer Inst.
94:1704–1711. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gallagher EJ and LeRoith D: Minireview:
IGF, insulin, and cancer. Endocrinology. 152:2546–2551. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cohen DH and LeRoith D: Obesity, type 2
diabetes, and cancer: The insulin and IGF connection. Endocr Relat
Cancer. 19:F27–F45. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tomblin JK and Salisbury TB: Insulin like
growth factor 2 regulation of aryl hydrocarbon receptor in MCF-7
breast cancer cells. Biochem Biophys Res Commun. 443:1092–1096.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Salisbury TB, Morris GZ, Tomblin JK,
Chaudhry AR, Cook CR and Santanam N: Aryl hydrocarbon receptor
ligands inhibit igf-ii and adipokine stimulated breast cancer cell
proliferation. ISRN Endocrinol. 2013:1048502013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dillon RL, Brown ST, Ling C, Shioda T and
Muller WJ: An EGR2/CITED1 transcription factor complex and the
14-3-3sigma tumor suppressor are involved in regulating ErbB2
expression in a transgenic-mouse model of human breast cancer. Mol
Cell Biol. 27:8648–8657. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sweeney C, Fambrough D, Huard C, Diamonti
AJ, Lander ES, Cantley LC and Carraway KL III: Growth
factor-specific signaling pathway stimulation and gene expression
mediated by ErbB receptors. J Biol Chem. 276:22685–22698. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Anderson E, Clarke RB and Howell A:
Estrogen responsiveness and control of normal human breast
proliferation. J Mammary Gland Biol Neoplasia. 3:23–35. 1998.
View Article : Google Scholar
|
|
36
|
Yang XR, Figueroa JD, Hewitt SM, Falk RT,
Pfeiffer RM, Lissowska J, Peplonska B, Brinton LA, Garcia-Closas M
and Sherman ME: Estrogen receptor and progesterone receptor
expression in normal terminal duct lobular units surrounding
invasive breast cancer. Breast Cancer Res Treat. 137:837–847. 2013.
View Article : Google Scholar
|
|
37
|
McKian KP, Reynolds CA, Visscher DW,
Nassar A, Radisky DC, Vierkant RA, Degnim AC, Boughey JC, Ghosh K,
Anderson SS, et al: Novel breast tissue feature strongly associated
with risk of breast cancer. J Clin Oncol. 27:5893–5898. 2009.
View Article : Google Scholar : PubMed/NCBI
|
